Language

Hepatic steatosis as a peripheral modulator of dopaminergic therapy responsiveness in Parkinson’s disease: evidence for a liver–brain physiology axis

Reference

Tungwongkitsiri A, Auvichayapat V, Phuenpathom W, Smitasiri T, Thaimai P, Ketloy C, et al. Hepatic steatosis as a peripheral modulator of dopaminergic therapy responsiveness in Parkinson’s disease: evidence for a liver–brain physiology axis. Physiology (Bethesda). 2026;41(S1).